首页> 外文OA文献 >G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation

【2h】

G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation

机译：小细胞肺癌患者预防中性发热的G-CSF，接受髓血压抑制肌肌肿瘤性化疗：META分析和药物经济评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
A. Messori; S. Trippoli; E. Tendi;
展开▼
作者单位

展开▼
年度 1996
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation. [J] . Messori A, Trippoli S, Tendi E Journal of Clinical Pharmacy and Therapeutics . 1996,第2期

机译：G-CSF用于预防小细胞肺癌患者的中性发热患者接受髓抑制型抗肿瘤化疗：META分析和药物经济评价。
2. Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923). [J] . Tjan Heijnen VC, Caleo S, Postmus PE, Annals of oncology: official journal of the European Society for Medical Oncology . 2003,第2期

机译：对接受化疗的小细胞肺癌患者进行抗生素预防的经济评估：EORTC双盲安慰剂对照的III期研究（08923）。
3. XM02, the first biosimilar G-CSF, is safe and effective in reducing the duration of severe neutropenia and incidence of febrile neutropenia in patients with small cell or non-small cell lung cancer receiving platinum-based chemotherapy. [J] . Gatzemeier U, Ciuleanu T, Dediu M, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2009,第6期

机译：XM02是首个生物仿制药G-CSF，在减少接受铂类化学疗法治疗的小细胞或非小细胞肺癌患者中严重中性粒细胞减少症的持续时间和发热性中性粒细胞减少症的发生率方面是安全有效的。
4. A side-effects mapping model in patients with lung, colorectal and breast cancer receiving chemotherapy [C] . Mazzocco Thomas, Hussain Amir 2011 IEEE 13th International Conference on e-Health Networking, Applications and Services . 2011

机译：肺癌，结直肠癌和乳腺癌患者接受化疗的副作用映射模型
5. Effects of primary prophylaxis of neutropenia on outcomes, utilization and expenditures for elderly breast cancer patients receiving chemotherapy. [D] . Rajan, Suja S. 2009

机译：一级预防中性粒细胞减少对老年接受化疗的乳腺癌患者的结局，利用和支出的影响。
6. Mould-active compared with fluconazole prophylaxis to prevent invasive fungaldiseases in cancer patients receiving chemotherapy or haematopoietic stem-celltransplantation: a systematic review and meta-analysis of randomised controlledtrials [O] . M C Ethier, M Science, J Beyene, 2012

机译：与氟康唑预防相比具有霉菌活性可预防侵入性真菌接受化疗或造血干细胞治疗的癌症患者的疾病移植：随机对照的系统评价和荟萃分析试验
7. XM02, the First Biosimilar G-CSF, is Safe and Effective in Reducing the Duration of Severe Neutropenia and Incidence of Febrile Neutropenia in Patients with Small Cell or Non-small Cell Lung Cancer Receiving Platinum-Based Chemotherapy [O] . Gatzemeier Ulrich, Ciuleanu Tudor, Dediu Mircea, 2009

机译：XM02是首个生物仿制药G-CSF，可安全有效地减少接受铂类化学疗法的小细胞或非小细胞肺癌患者的严重中性粒细胞减少症的持续时间和发热性中性粒细胞减少症的发生

G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation

著录项

相似文献

相关主题

期刊订阅